BioSpace News Archive

WestCMR Offers Incentives to Perform Sustainable Practices Year-Round

Health Canada is advising Canadians who use vaping products to monitor themselves for symptoms of pulmonary illness and to seek medical attention promptly if they have concerns about their health..

Consumers and pharmacists should check that devices can be removed from their carrier tubes with ease

Theratechnologies Inc. is pleased to announce that results from a recent trial conducted at the Massachusetts General Hospital and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health on the effects of tesamorelin on Non-alcoholic Fatty Liver Disease in HIV were published in the Lancet HIV.

REGENXBIO Inc. announced interim data from the ongoing Phase I/IIa trial of RGX-314 for the treatment of wet age-related macular degeneration The results were presented by Jeffrey S. Heier, M.D., Co-President and Director of Retina Research at Ophthalmic Consultants of Boston and primary investigator for the trial, in a podium presentation at the Retina Subspecialty Day program of the American Academy of Ophthalmology 2019 Annual Meeting in San Francisco, CA.

Zero anti-VEGF rescue injections required in the first cohort and durable efficacy with median follow up of 34 weeks

Two-year results from CEDAR and SEQUOIA demonstrate that vision gains observed after one year with every 8-week and every 12-week dosing were maintained in the second year

Promising clinical durability observed with 80% of wet AMD treated eyes and 78% of DME treated eyes extended to four months or longer without receiving retreatment

Promising clinical durability observed with 80% of wet AMD treated eyes and 78% of DME treated eyes extended to four months or longer without receiving retreatment

The global pharmaceutical contract packaging market is expected to post a CAGR of more than 17% during the period 2019-2023, according to the latest market research report by Technavio. Request a free sample report.